213 related articles for article (PubMed ID: 32346549)
21. Downstream process design for Gag HIV-1 based virus-like particles.
Lorenzo E; Miranda L; Gòdia F; Cervera L
Biotechnol Bioeng; 2023 Sep; 120(9):2672-2684. PubMed ID: 37148527
[TBL] [Abstract][Full Text] [Related]
22. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
23. A new simplified clarification approach for lentiviral vectors using diatomaceous earth improves throughput and safe handling.
Labisch JJ; Bollmann F; Wolff MW; Pflanz K
J Biotechnol; 2021 Jan; 326():11-20. PubMed ID: 33301854
[TBL] [Abstract][Full Text] [Related]
24. Preparation of pure, high titer, pseudoinfectious Flavivirus particles by hollow fiber tangential flow filtration and anion exchange chromatography.
Mundle ST; Giel-Moloney M; Kleanthous H; Pugachev KV; Anderson SF
Vaccine; 2015 Aug; 33(35):4255-60. PubMed ID: 25498209
[TBL] [Abstract][Full Text] [Related]
25. A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.
Marino MP; Panigaj M; Ou W; Manirarora J; Wei CH; Reiser J
Gene Ther; 2015 Mar; 22(3):280-5. PubMed ID: 25608718
[TBL] [Abstract][Full Text] [Related]
26. Large-scale production of lentiviral vectors using multilayer cell factories.
Rout-Pitt N; McCarron A; McIntyre C; Parsons D; Donnelley M
J Biol Methods; 2018; 5(2):e90. PubMed ID: 31453241
[TBL] [Abstract][Full Text] [Related]
27. Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor.
Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101209. PubMed ID: 38435128
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous clarification of Escherichia coli culture and purification of extracellularly produced penicillin G acylase using tangential flow filtration and anion-exchange membrane chromatography (TFF-AEMC).
Orr V; Scharer J; Moo-Young M; Honeyman CH; Fenner D; Crossley L; Suen SY; Chou CP
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():71-8. PubMed ID: 22709629
[TBL] [Abstract][Full Text] [Related]
29. Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.
Nasimuzzaman M; Lynn D; Ernst R; Beuerlein M; Smith RH; Shrestha A; Cross S; Link K; Lutzko C; Nordling D; Russell DW; Larochelle A; Malik P; Van der Loo JC
Mol Ther Methods Clin Dev; 2016; 3():16004. PubMed ID: 27722179
[TBL] [Abstract][Full Text] [Related]
30. Advances in Lentivirus Purification.
Moreira AS; Cavaco DG; Faria TQ; Alves PM; Carrondo MJT; Peixoto C
Biotechnol J; 2021 Jan; 16(1):e2000019. PubMed ID: 33089626
[TBL] [Abstract][Full Text] [Related]
31. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
32. Large-scale purification of pharmaceutical-grade plasmid DNA using tangential flow filtration and multi-step chromatography.
Sun B; Yu X; Yin Y; Liu X; Wu Y; Chen Y; Zhang X; Jiang C; Kong W
J Biosci Bioeng; 2013 Sep; 116(3):281-6. PubMed ID: 23660074
[TBL] [Abstract][Full Text] [Related]
33. High yield sterile filtration process for highly concentrated lentiviral vectors.
Vogel JE; Terrao M; Schwingal S; Kapitza L; Brigulla D; Pirzas V; Laux H; Brandt T
Biotechnol J; 2024 Mar; 19(3):e2300348. PubMed ID: 38472091
[TBL] [Abstract][Full Text] [Related]
34. Upscaling of lentiviral vector production by tangential flow filtration.
Geraerts M; Michiels M; Baekelandt V; Debyser Z; Gijsbers R
J Gene Med; 2005 Oct; 7(10):1299-310. PubMed ID: 15906396
[TBL] [Abstract][Full Text] [Related]
35. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
36. Time-dependent sorption behavior of lentiviral vectors during anion-exchange chromatography.
Pamenter G; Davies L; Knevelman C; Miskin J; Mitrophanous K; Dikicioglu D; Bracewell DG
Biotechnol Bioeng; 2023 Aug; 120(8):2269-2282. PubMed ID: 37386920
[TBL] [Abstract][Full Text] [Related]
37. Investigating the combination of single-pass tangential flow filtration and anion exchange chromatography for intensified mAb polishing.
Elich T; Goodrich E; Lutz H; Mehta U
Biotechnol Prog; 2019 Sep; 35(5):e2862. PubMed ID: 31168950
[TBL] [Abstract][Full Text] [Related]
38. Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes.
Tomás HA; Mestre DA; Rodrigues AF; Guerreiro MR; Carrondo MJT; Coroadinha AS
Mol Ther Methods Clin Dev; 2019 Dec; 15():1-8. PubMed ID: 31528654
[TBL] [Abstract][Full Text] [Related]
39. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
40. Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography.
Transfiguracion J; Tran MY; Lanthier S; Tremblay S; Coulombe N; Acchione M; Kamen AA
Mol Ther Methods Clin Dev; 2020 Sep; 18():803-810. PubMed ID: 32953931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
